Emmessar Biotech & Nutrition has informed shareholders about the availability of its Annual Report for FY 2025-26 and the Notice for the 34th Annual General Meeting.

For members whose email addresses are not registered, a physical communication has been dispatched guiding them to access these documents on the company's website and the stock exchange's website.

The AGM will be held on Tuesday, September 29, 2026, at 10:30 a.m. via video conference.

Shareholders are also reminded to update their KYC details and dematerialize physical shares for efficient future communications.